Self-microemulsifying drug delivery system
A self-microemulsifying drug delivery system (SMEDDS) is a drug delivery system that uses a microemulsion achieved by chemical rather than mechanical means. That is, by an intrinsic property of the drug formulation, rather than by special mixing and handling. It employs the familiar ouzo effect displayed by anethole in many anise-flavored liquors. Microemulsions have significant potential for use in drug delivery, and SMEDDS (including so-called "U-type" microemulsions) are the best of these systems identified to date.[1] SMEDDS are of particular value in increasing the absorption of lipophilic drugs taken by mouth.
SMEDDS in research or development include formulations of the drugs
Actual applications of Self-microemulsifying drug delivery system' (SMEDDS) remain rare. The first drug marketed as a SMEDDS was
Within the last years SMEDDS were also utilized for the oral administration of biologics. Due to ion pairing with appropriate surfactants [58] these mainly hydrophilic macromolecular drugs can be incorporated in the lipophilic phase of SMEDDS. Provided that the oily droplets being formed in the gut are sufficiently stable towards lipases,[59] can permeate the mucus gel layer in sufficient quantities [60] and exhibit permeation enhancing properties [61] the oral bioavailability of various biologics can be strongly improved [62]
SMEDDS offer numerous advantages: spontaneous formation, ease of manufacture, thermodynamic stability, and improved solubilization of bioactive materials.[1] Improved solubility contributes to faster release rates and greater bioavailability. For many drugs taken by mouth, faster release rates improve the drug acceptance by consumers. Greater bioavailability means that less drug need be used; this may lower cost, and does lower the stomach irritation and toxicity of drugs taken by mouth.
For oral use, SMEDDS may be formulated as liquids or solids, the solids packaged in capsules or tablets. Limited studies comparing these report that in terms of bioavailability liquid SMEDDS are superior to solid SMEDDS,[21] which are superior to conventional tablets.[21][42][47] Liquid SMEDDS have also shown value in injectable (IV and urethral) formulations and in a topical (oral) spray.[36]
See also
References
- ^ PMID 17229398.
- PMID 16824723.
- PMID 18242895.
- PMID 19160780.
- PMID 18782611.
- PMID 19124065.
- PMID 18175953.
- PMID 19040178.
- S2CID 7127624.
- PMID 18446456.
- S2CID 97608266.
- PMID 18973026.
- from the original on 2011-07-06. Retrieved 2009-03-13.
- PMID 16198521.
- PMID 18664206.
- PMID 18652886.
- PMID 13678797.
- ^ PMID 15979260.
- ^ PMID 17158039.
- PMID 18644442.
- ^ PMID 18603415.
- PMID 18541418.
- PMID 18473177.
- PMID 18434109.
- S2CID 24590025.
- PMID 15501011.
- PMID 16650738.
- PMID 17383165.
- PMID 18379060.
- PMID 18367386.
- PMID 18178070.
- PMID 18170981.
- S2CID 3119405.
- PMID 15072783.
- S2CID 37334831.
- ^ PMID 17531411.
- PMID 16527467.
- S2CID 22169992.
- PMID 17260899.
- S2CID 9408964.
- PMID 15627278.
- ^ PMID 17076244.
- PMID 17918441.
- PMID 16499080.
- PMID 16454200.
- S2CID 22542504.
- ^ PMID 16631328.
- S2CID 12794172.
- S2CID 11978203.
- PMID 15908031.
- PMID 15784337.
- PMID 15607255.
- PMID 15577219.
- S2CID 8763220.
- PMID 12776806.
- S2CID 32771754.
- S2CID 28468973.
- PMID 26485536.
- S2CID 21890042.
- PMID 24258284.
- PMID 15784337.
- PMID 24879935.
Further reading
- Singh, A.; Singh, V.; Juyal, D.; Rawat, G. (2015). "Self emulsifying systems: A review". Asian Journal of Pharmaceutics. 9 (1): 13. .
- Cherniakov, I.; Domb, A. J.; Hoffman, A. (2015). "Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects". Expert Opinion on Drug Delivery. 12 (7): 1121–1133. S2CID 207490348.
- Weerapol, Y.; Limmatvapirat, S.; Takeuchi, H.; Sriamornsak, P. (2015). "Fabrication of spontaneous emulsifying powders for improved dissolution of poorly water-soluble drugs". Powder Technology. 271: 100–108. .